Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Formoterol A
Formoterol B (placebo)
Locations
1
United States
VA Palo Alto Health Care System
Palo Alto, California, United States
Start Date
January 1, 2023
Primary Completion Date
April 1, 2025
Completion Date
July 1, 2025
Last Updated
September 16, 2020
NCT07033494
NCT06159673
NCT07457138
NCT07171450
NCT07214727
NCT07422857
Lead Sponsor
Palo Alto Veterans Institute for Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions